HCM Q4 2019 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$53M-54.5% YoY

Gross Profit

-$61M-114.6% margin

Operating Income

$101M190.5% margin

Net Income

-$37M-70.7% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+7.1%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$20M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$465M

Total Liabilities

$152M

Stockholders' Equity

$288M

Cash & Equivalents

$121M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$116M	-54.5%
Gross Profit	-$61M	$41M	-246.6%
Operating Income	$101M	-$40M	+349.2%
Net Income	-$37M	-$44M	+14.5%

Revenue Segments

Product

$46M90%

Collaboration Research And Development

$5M10%

Research And Development Services

$121,0000%

Other Collaboration Royalties Revenue

$91,0000%